Pierre Quartier

22.6k total citations · 2 hit papers
239 papers, 8.8k citations indexed

About

Pierre Quartier is a scholar working on Hematology, Rheumatology and Speech and Hearing. According to data from OpenAlex, Pierre Quartier has authored 239 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Hematology, 81 papers in Rheumatology and 53 papers in Speech and Hearing. Recurrent topics in Pierre Quartier's work include Autoimmune and Inflammatory Disorders Research (112 papers), Adolescent and Pediatric Healthcare (53 papers) and Inflammasome and immune disorders (43 papers). Pierre Quartier is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (112 papers), Adolescent and Pediatric Healthcare (53 papers) and Inflammasome and immune disorders (43 papers). Pierre Quartier collaborates with scholars based in France, United States and Italy. Pierre Quartier's co-authors include Anne‐Marie Prieur, Brigitte Bader‐Meunier, Isabelle Koné‐Paut, Alain Fischer, Geneviève de Saint Basile, Bénédicte Neven, Helen J. Lachmann, Jean‐Laurent Casanova, Philip N. Hawkins and Stéphanie Certain and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Pierre Quartier

215 papers receiving 8.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

2009 627 citations Isabelle Koné‐Paut, É. Hachulla et al. profile →
Chronic Infantile Neurological Cutaneous and Articular Syndrome Is Caused by Mutations in CIAS1, a Gene Highly Expressed in Polymorphonuclear Cells and Chondrocytes

2002 544 citations Pierre Quartier et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Pierre Quartier	3.4k	3.2k	3.1k	1.8k	1.5k	239	8.8k
Nico Wulffraat	3.2k 0.9×	2.2k 0.7×	5.1k 1.6×	2.2k 1.2×	1.4k 1.0×	242	9.8k
Brigitte Bader‐Meunier	1.9k 0.6×	1.6k 0.5×	1.9k 0.6×	1.8k 1.0×	1.1k 0.7×	212	5.8k
David N. Glass	3.3k 1.0×	1.8k 0.6×	5.9k 1.9×	3.2k 1.7×	1.1k 0.8×	120	9.6k
Seza Özen	3.2k 0.9×	5.7k 1.8×	1.6k 0.5×	1.9k 1.0×	1.7k 1.1×	335	9.5k
Gerd Horneff	1.6k 0.5×	1.4k 0.4×	3.2k 1.0×	1.3k 0.7×	847 0.6×	324	5.5k
Isabelle Koné‐Paut	2.2k 0.6×	2.9k 0.9×	2.1k 0.7×	1.5k 0.8×	1.5k 1.0×	201	6.1k
Alexei A. Grom	3.6k 1.1×	1.8k 0.6×	5.0k 1.6×	799 0.4×	1.4k 1.0×	122	7.4k
Anne‐Marie Prieur	1.9k 0.6×	2.2k 0.7×	4.1k 1.3×	1.8k 1.0×	1.2k 0.8×	55	6.6k
Marilynn Punaro	3.2k 1.0×	1.4k 0.4×	1.2k 0.4×	1.5k 0.8×	451 0.3×	58	5.3k
Salvatore Albani	2.3k 0.7×	1.5k 0.5×	1.2k 0.4×	913 0.5×	395 0.3×	121	5.2k

Countries citing papers authored by Pierre Quartier

Since Specialization

Citations

This map shows the geographic impact of Pierre Quartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Quartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Quartier more than expected).

Fields of papers citing papers by Pierre Quartier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Quartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Quartier. The network helps show where Pierre Quartier may publish in the future.

Co-authorship network of co-authors of Pierre Quartier

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Quartier. A scholar is included among the top collaborators of Pierre Quartier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Quartier. Pierre Quartier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramanan, Athimalaipet V, Catherine Guly, Gabriele Simonini, et al.. (2025). Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis–Associated Uveitis or Chronic Anterior Antinuclear Antibody–Positive Uveitis. Arthritis Care & Research.

Stolzenberg, Marie‐Claude, Mélanie Parisot, Cécile Masson, et al.. (2024). Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome. Cell Death and Disease. 15(5). 315–315. 3 indexed citations

Greco, Céline, et al.. (2023). Medical child abuse: Medical history and red flags in French adolescents. Child Abuse & Neglect. 146. 106523–106523. 1 indexed citations

Bader‐Meunier, Brigitte, Sylvain Breton, Darragh Duffy, et al.. (2023). Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?. Lara D. Veeken. 62(8). e242–e245. 1 indexed citations

Quartier, Pierre, Lien De Somer, Bernard Lauwerys, et al.. (2023). Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis. Lara D. Veeken. 63(3). 594–607. 4 indexed citations

Quartier, Pierre. (2022). Systemic Juvenile Idiopathic Arthritis/Pediatric Still’s Disease, a Syndrome but Several Clinical Forms: Recent Therapeutic Approaches. Journal of Clinical Medicine. 11(5). 1357–1357. 8 indexed citations

Chbihi, Marwa, Quentin Riller, R. Brousse, et al.. (2022). Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide. Journal of Nephrology. 36(3). 829–839. 2 indexed citations

Rodero, Mathieu P., Florence A. Aeschlimann, François‐Jérôme Authier, et al.. (2022). Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study. Lara D. Veeken. 61(11). 4514–4520. 3 indexed citations

Roy, Pascal, Alexandre Bélot, Pierre Quartier, et al.. (2022). Human Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Drivers of Vaccination. Journal of Clinical Medicine. 11(14). 4137–4137. 3 indexed citations

10.

Rodrigues, François, Laurence Cuisset, Irina Giurgea, et al.. (2022). AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review. Lara D. Veeken. 61(12). 4827–4834. 10 indexed citations

11.

Voyer, Tom Le, Cyril Gitiaux, François‐Jérôme Authier, et al.. (2021). JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study. Lara D. Veeken. 60(12). 5801–5808. 54 indexed citations

12.

Bader‐Meunier, Brigitte, Fabienne Charbit‐Henrion, Ulrich Meinzer, et al.. (2021). Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 27(11). 1853–1857. 8 indexed citations

13.

López-Corbeto, Mireia, et al.. (2021). A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report. Pediatric Rheumatology. 19(1). 168–168. 3 indexed citations

14.

Park, K.T., Kevin Baszis, Charlotte Borocco, et al.. (2020). Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 48(4). 567–574. 7 indexed citations

15.

Quartier, Pierre, Е.I. Alexeeva, Tamás Constantin, et al.. (2020). Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study. Arthritis & Rheumatology. 73(2). 336–346. 23 indexed citations

16.

Morelle, Guillaume, J. Gueudry, Florence Uettwiller, et al.. (2019). Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort. RMD Open. 5(2). e000933–e000933. 27 indexed citations

17.

Breton, Sylvain, Florence Uettwiller, Isabelle Melki, et al.. (2018). Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre. Pediatric Rheumatology. 16(1). 21–21. 36 indexed citations

18.

Lagarde, Stanislas, Nathalie Villeneuve, Agnès Trébuchon, et al.. (2016). Anti–tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study. Epilepsia. 57(6). 956–966. 75 indexed citations

19.

Melki, Isabelle, Karen Lambot, Laurence Jonard, et al.. (2013). Mutation in the SLC29A3 Gene: A New Cause of a Monogenic, Autoinflammatory Condition. PEDIATRICS. 131(4). e1308–e1313. 55 indexed citations

20.

Ruperto, Nicolino, Pierre Quartier, Nico Wulffraat, et al.. (2008). 2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA). Pediatric Rheumatology. 6(S1). 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact